- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Severe refractory asthma
Total 25237 results
-
National Institute of Allergy and Infectious Diseases...Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN)CompletedCOVID-19 | SARS-CoV Infection | Allergic Reaction | Mast Cell DisorderUnited States
-
Helsinki University Central HospitalIda Montini foundation, www.tb-foundation.orgCompleted
-
Connecticut Children's Medical CenterUConn HealthCompleted
-
AstraZenecaCompleted
-
Queen's University, BelfastKing's College LondonCompleted
-
Weill Medical College of Cornell UniversityCompleted
-
Pharmacyclics LLC.Janssen Research & Development, LLCActive, not recruitingChronic Graft Versus Host DiseaseUnited States, Spain, Korea, Republic of, Australia, Austria, Canada, France, Germany, Israel, Italy, Netherlands, Russian Federation, United Kingdom
-
Novartis PharmaceuticalsCompleted
-
University of California, DavisTerminated
-
Karl Landsteiner Institute for Clinical and Experimental...Universitätsklinik für Innere Medizin II, PulmologieCompleted
-
GlaxoSmithKlineIqvia Pty LtdActive, not recruitingAsthmaUnited States, Japan, Poland, Spain, Italy, Australia, Taiwan, France, Hungary, Canada, Czechia
-
AstraZenecaCompletedIn Adult Patients of Severe Asthma With Eosinophilic Phenotype in IndiaIndia
-
AbbVieCompletedAtopic DermatitisUnited States, Australia, Canada, Croatia, Czechia, Finland, France, Germany, Hungary, Ireland, Israel, Italy, Malaysia, Netherlands, New Zealand, Norway, Poland, Singapore, Spain, Taiwan, Ukraine, United Kingdom
-
AmgenWithdrawn
-
Gert-Jan BraunstahlGenzyme, a Sanofi CompanyCompleted
-
The Cleveland ClinicUniversity of Virginia; Case Western Reserve UniversityActive, not recruiting
-
Federal University of BahiaConselho Nacional de Desenvolvimento Científico e TecnológicoCompletedQuality of Life | AsthmaBrazil
-
Regeneron PharmaceuticalsSanofiCompletedModerate-to-severe Atopic DermatitisUnited States
-
AstraZenecaIqvia Pty LtdTerminatedAtopic DermatitisUnited States, France, Korea, Republic of, Spain, Czechia, Bulgaria, Australia, Poland
-
AstraZenecaCompleted
-
University Hospital, MontpellierCompletedSevere Asthma | Allergic Bronchopulmonary Aspergillosis (ABPA)France
-
Bio-Thera SolutionsCompleted
-
Novartis PharmaceuticalsCompleted
-
University of MichiganRegeneron PharmaceuticalsCompleted
-
AnaptysBio, Inc.CompletedEosinophilic AsthmaUnited Kingdom, United States
-
University of MichiganTeva Branded Pharmaceutical Products R&D, Inc.Active, not recruiting
-
Novartis PharmaceuticalsTerminatedAsthmaGermany, United States, Belgium, Poland, Latvia, Argentina, Guatemala, Philippines, Slovakia, Czechia, Hungary, Russian Federation, Japan, Bulgaria, Canada
-
University of Wisconsin, MadisonWashington University School of Medicine; National Heart, Lung, and Blood Institute... and other collaboratorsCompleted
-
Milton S. Hershey Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruiting
-
Phramongkutklao College of Medicine and HospitalCompletedDengue | Dengue With Warning Signs | Dengue Shock SyndromeThailand
-
SanofiRegeneron PharmaceuticalsActive, not recruitingAsthmaPortugal, Ukraine, Spain, Taiwan, Sweden, United States, Bulgaria, Denmark, France, Italy, Romania, Saudi Arabia, United Kingdom
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...Active, not recruitingNon-Hodgkin's Lymphoma | Acute Lymphoblastic Leukemia | Chronic Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
Istituti Clinici Scientifici Maugeri SpATerminated
-
Aldeyra Therapeutics, Inc.CompletedChronic CoughUnited States
-
JemincareCompleted
-
The Cleveland ClinicCompletedAplastic AnemiaUnited States
-
AstraZenecaAmgenCompletedModerate to Severe AsthmaUnited States
-
University of California, San FranciscoNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
AstraZenecaCompletedAsthmaUnited States, Canada, Denmark, France, Italy, Sweden, United Kingdom, Belgium, Taiwan, Brazil, Poland, Russian Federation, Spain, Germany, Argentina, Colombia, Mexico
-
AstraZenecaAmgenCompletedAsthmaUnited States, Austria, Canada, France, Germany, Taiwan, Vietnam, Korea, Republic of, Brazil, Turkey, Argentina, Australia, Israel, Poland, Russian Federation, Saudi Arabia, South Africa, Ukraine
-
Austin HealthUniversity of MelbourneCompletedUlcerative ColitisAustralia
-
Makerere UniversityCompletedSevere AsthmaEthiopia, Kenya, Netherlands, Uganda
-
AnaptysBio, Inc.CompletedAtopic DermatitisUnited States, Poland, Germany, United Kingdom, Czechia, Canada
-
Tufts Medical CenterCompleted
-
AstraZenecaPPD; Parexel; Covance; Iqvia Pty LtdCompletedSevere Uncontrolled AsthmaUnited States, Japan
-
University of AarhusAarhus University Hospital; ADS AIPHIA Development Services AGTerminatedCirrhosis, Liver | Ascites HepaticDenmark
-
Genentech, Inc.CompletedAtopic DermatitisGermany, United States, Poland
-
Chiesi Farmaceutici S.p.A.CompletedSevere Combined Immunodeficiency | Adenosine Deaminase DeficiencyUnited States
-
AstraZenecaCompletedNasal Polyps | Severe Eosinophilic AsthmaUnited States, France, Italy, Spain, Germany, Japan
-
CinnagenCompletedAllergic Asthma | Uncontrolled Moderate to SevereIran, Islamic Republic of